Company: FGMCU
Filing Date: 2025-12-30
Form Type: S-4/A
Source: 0001104659-25-124947
Chunk: 531

Company: FG Merger II Corp.
Filing Date: 2025-12-30
Form: S-4/A
Chunk 531
---
 ”).

<div align='center'>F-26</div>

NOTE 7. STOCKHOLDERS’ EQUITY Common Stock — The Company is authorized to issue 100,000,000 shares of common stock, par value $ 0.0001 . On September 30, 2025, there were 2,295,800 common shares outstanding, excluding 8,000,000 shares subject to possible redemption. Rights — Public Rights will entitle the holder to receive one -tenth common share per each Public Right. On September 30, 2025, the Company had 829,580 total rights including 800,000 Public Rights outstanding at the close of the IPO. Warrants — The $ 15 Private Warrants entitles the holder to purchase one common share at an exercise price of $ 15.00 per each share, is exercisable for a period of 10 years from the date of Business Combination, is non-redeemable, and may be exercised on a cashless basis. Additionally, $ 15 Private Warrants and the shares issuable upon the exercise of the $ 15 Private Warrants are not to be transferable, assignable or salable until after the completion of a Business Combination, subject to certain limited exceptions. The Company have 1,000,000 $ 15 Private Warrant outstanding at the close of the IPO. The exercise price and number of ordinary shares issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, extraordinary dividend or recapitalization, reorganization, merger or consolidation. However, except as described above, the warrants will not be adjusted for issuances of common stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Period, the $ 15 Private Warrants may expire worthless.

NOTE 8. SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to November 5, 2025, the date that the financial statements were issued. On November 3, 2025, Company entered into an amendment (the “ Amendment ”) to the Merger Agreement with BOXABL. Pursuant to the Amendment, the parties to the Merger Agreement agreed to extend the Agreement End Date for the Merger Agreement from December 31, 2025, to March 31, 2026.

<div align